Alliancebernstein LP Increased By $1.02 Million Its Argan (AGX) Stake; Dynavax Technologies (DVAX) Had 5 Bullish Analysts

December 11, 2017 - By Michael Collier

Alliancebernstein Lp increased Argan Inc (AGX) stake by 37.57% reported in 2017Q2 SEC filing. Alliancebernstein Lp acquired 17,270 shares as Argan Inc (AGX)’s stock declined 5.69%. The Alliancebernstein Lp holds 63,240 shares with $3.79 million value, up from 45,970 last quarter. Argan Inc now has $735.45 million valuation. The stock increased 7.13% or $3.15 during the last trading session, reaching $47.3. About 993,836 shares traded or 414.32% up from the average. Argan, Inc. (NYSE:AGX) has risen 101.20% since December 11, 2016 and is uptrending. It has outperformed by 84.50% the S&P500.

Among 6 analysts covering Dynavax Technologies (NASDAQ:DVAX), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Dynavax Technologies had 19 analyst reports since August 12, 2015 according to SRatingsIntel. William Blair maintained the shares of DVAX in report on Friday, July 21 with “Buy” rating. The firm has “Buy” rating by William Blair given on Monday, August 7. RBC Capital Markets downgraded the shares of DVAX in report on Thursday, April 28 to “Sector Perform” rating. RBC Capital Markets maintained Dynavax Technologies Corporation (NASDAQ:DVAX) on Wednesday, July 26 with “Hold” rating. The stock has “Outperform” rating by RBC Capital Markets on Monday, July 31. RBC Capital Markets maintained Dynavax Technologies Corporation (NASDAQ:DVAX) rating on Sunday, October 29. RBC Capital Markets has “Buy” rating and $28.0 target. Cowen & Co maintained it with “Buy” rating and $3000 target in Thursday, August 3 report. Cowen & Co maintained the stock with “Buy” rating in Friday, July 28 report. The firm has “Buy” rating given on Thursday, September 14 by Cantor Fitzgerald. On Friday, September 1 the stock rating was maintained by RBC Capital Markets with “Buy”. See Dynavax Technologies Corporation (NASDAQ:DVAX) latest ratings:

09/11/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $25.0 Maintain
29/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $28.0 Maintain
27/09/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $24.0 Maintain
25/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $28.0 Maintain
14/09/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $24.0 Initiate
01/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $26.0 Maintain
07/08/2017 Broker: William Blair Rating: Buy New Target: $30.0000 Maintain
03/08/2017 Broker: Cowen & Co Rating: Buy New Target: $30.0000 Maintain
31/07/2017 Broker: William Blair Rating: Buy New Target: $30.0000 Maintain
31/07/2017 Broker: J.P. Morgan Rating: Buy Upgrade

The stock increased 3.68% or $0.65 during the last trading session, reaching $18.3. About 906,795 shares traded. Dynavax Technologies Corporation (NASDAQ:DVAX) has declined 63.84% since December 11, 2016 and is downtrending. It has underperformed by 80.54% the S&P500.

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the bodyÂ’s innate and adaptive immune responses through toll-like receptor stimulation. The company has market cap of $1.11 billion. The Company’s product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. It currently has negative earnings. The companyÂ’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies.

Investors sentiment decreased to 2.06 in 2017 Q2. Its down 0.27, from 2.33 in 2017Q1. It dropped, as 8 investors sold Dynavax Technologies Corporation shares while 19 reduced holdings. 20 funds opened positions while 43 raised stakes. 34.68 million shares or 16.64% more from 29.73 million shares in 2017Q1 were reported. Susquehanna Intll Gp Llp holds 453,088 shares. Wells Fargo & Co Mn invested in 0% or 62,643 shares. C Ww Gp A S has invested 0.1% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX). Howard Hughes Institute owns 21,355 shares or 0.04% of their US portfolio. Moreover, Reilly Finance Limited Liability Company has 0% invested in Dynavax Technologies Corporation (NASDAQ:DVAX) for 30 shares. Dekabank Deutsche Girozentrale owns 20,000 shares for 0% of their portfolio. Lord Abbett And Company Ltd Liability Corporation invested in 0.02% or 805,920 shares. Creative Planning has invested 0.01% in Dynavax Technologies Corporation (NASDAQ:DVAX). The New York-based Pointstate Capital L P has invested 0.15% in Dynavax Technologies Corporation (NASDAQ:DVAX). State Board Of Administration Of Florida Retirement, a Florida-based fund reported 19,270 shares. State Of Wisconsin Inv Board has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). Point72 Asset Mngmt Limited Partnership accumulated 1.36 million shares. 28,324 are held by Mariner Wealth Advsr Ltd Com. Manufacturers Life Insurance Com The owns 41,320 shares or 0% of their US portfolio. Swiss Retail Bank reported 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX).

Alliancebernstein Lp decreased Akorn Inc (NASDAQ:AKRX) stake by 1.27M shares to 1.16M valued at $38.92M in 2017Q2. It also reduced Bruker Corp (NASDAQ:BRKR) stake by 377,723 shares and now owns 2.17 million shares. Cavium Inc (NASDAQ:CAVM) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com